Skip to main navigation
Tracon Tracon
  • About
    • Management
    • Board of Directors
    • Scientific Advisory Board
  • Pipeline
    • ENVAFOLIMAB (KN035)
    • TRC102
    • TRC253
    • TJ004309
  • Clinical Trials
  • Partners
  • News
    • Press Releases
    • Publications
    • VIDEO PRESENTATIONS
  • Investors

    Investor Relations

    • Press Releases
    • Events & Presentations
    • Corporate Governance
      • Management
      • Board of Directors
      • Board Committees
    • Financials & Filings
      • SEC Filings
      • Annual Reports & Proxies
      • Quarterly Results
    • Stock Information
      • Historical Price Lookup
      • Investment Calculator
    • Investor FAQ
    • Contact
  • Contact
  • Community

PRESS RELEASES

More events are coming soon.

Keyword Search

  • 08/02/06
    Summary ToggleTracon Pharmaceuticals appoints Charles P.Theuer, M.D., Ph.D as President and Chief Executive Officer
     Printer Friendly
    Release4158c9c2-d21b-4a4a-a11a-73b709a9bca5_2010122.pdf 8.4 KB
  • 03/14/06
    Summary ToggleTRACON Pharmaceuticals assembles industry-leading management team to support development of targeted cancer therapy pipeline
     Printer Friendly
    Release838f81f6-771f-40b6-99e9-8be67b7a48db_2010123.pdf 17.6 KB
  • 04/16/05
    Summary ToggleLexington Pharmaceuticals changes name to TRACON Pharmaceuticals, Inc. Lexington Pharmaceuticals announced that it has changed its name to TRACON Pharmaceuticals, Inc., and has moved the company from New York, New York to San Diego, California.
     Printer Friendly
    Releasefa84284c-e508-4765-90ce-d3ad5de2a7cf_2010130.pdf 6.1 KB
  • 04/01/05
    Summary ToggleLexington Pharmaceuticals names Bert Liang, MD MBA as President and CEO. Dr. Liang was formerly Vice President of New Ventures, at Biogen Idec.
     Printer Friendly
    Release64aedcd4-e4e8-47eb-b2c1-fb488d84bb47_2010131.pdf 5.4 KB

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 21
  • Page 22
  • Page 23
  • Current page 24
  •  Print Page
  •  RSS Feeds
  •  Email Alerts
  •  Contact
4350 La Jolla Village Drive
Suite 800
San Diego, CA 92122
Phone: (858) 550-0780
Fax: (858) 550-0786
Email: info@traconpharma.com

About

  • Management
  • Board of Directors
  • Scientific Advisory Board

News

  • Press Releases
  • Publications

Pipeline

  • Envafolimab (KN035)
  • TRC102
  • TRC253

Partners


Contact

Clinical Trials


Investors

Investor Relations

  • Press Releases
  • Events & Presentations
  • Corporate Governance
    • Management
    • Board of Directors
    • Board Committees
  • Financials & Filings
    • SEC Filings
    • Annual Reports & Proxies
    • Quarterly Results
  • Stock Information
    • Historical Price Lookup
    • Investment Calculator
  • Investor FAQ
  • Contact
Copyright © TRACON Pharmaceuticals, Inc. 2021